Page last updated: 2024-11-02

pentobarbital and Spinal Cord Diseases

pentobarbital has been researched along with Spinal Cord Diseases in 2 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Spinal Cord Diseases: Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Praestholm, J1
Matsushita, A1
Smith, CM1

Other Studies

2 other studies available for pentobarbital and Spinal Cord Diseases

ArticleYear
Water-soluble contrast medium myelography in the experimental animal. A preliminary report.
    Acta radiologica: diagnosis, 1972, Volume: 13, Issue:0

    Topics: Anesthesia, Intravenous; Animals; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Injections, Spi

1972
Muscle relaxants on postischemic spinal rigidity in the rat.
    Brain research, 1970, May-04, Volume: 19, Issue:3

    Topics: Animals; Chlorpromazine; Contracture; Decerebrate State; Depression, Chemical; Electromyography; Hin

1970